TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive In Brief: Whittaker Corp, Trying To Hire NCI Director; Environmental Carcinogenesis On NCAB Agenda February 13, 1976
TCL Archive CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely May 23, 2003
TCL Archive General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position” March 12, 1993
